Sessa Capital IM, L.P.
Sessa Capital IM, L.P. reported 30 holdings worth US$5.98B as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 14, 2026
Sessa Capital IM, L.P. reported 30 holdings worth US$5.98B as of Jun 30, 2026. Largest: Humana Inc., Warner Bros. Discovery, Inc. - Series A and Kimberly-clark Corporation. Filed Aug 14, 2026 (Form 13F).
- Holdings
- 30
- Value as reported
- US$5.98B
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Humana Inc. | 3.73M | US$1.48B | 24.8% |
| Warner Bros. Discovery, Inc. - Series A | 30.2M | US$804M | 13.4% |
| Kimberly-clark Corporation | 5.21M | US$572M | 9.6% |
| Sotera Health Company | 27.1M | US$480M | 8.0% |
| Pacific Gas & Electric Co. | 24.6M | US$413M | 6.9% |
| Ally Financial Inc. | 8.49M | US$390M | 6.5% |
| Capital One Financial Corporation | 1.56M | US$313M | 5.2% |
| Illumina, Inc. | 1.12M | US$197M | 3.3% |
| Teleflex Incorporated | 1.53M | US$193M | 3.2% |
| Grail, Inc. | 2.04M | US$139M | 2.3% |
| Axalta Coating Systems Ltd. | 3.54M | US$121M | 2.0% |
| Coupang, Inc. | 5.19M | US$90.2M | 1.5% |
| Fortrea Holdings Inc. | 4.59M | US$79.9M | 1.3% |
| Tandem Diabetes Care, Inc. | 5.1M | US$77M | 1.3% |
| Roku, Inc. | 350K | US$48.3M | 0.81% |
| Lexicon Pharmaceuticals, Inc. | 19M | US$45.5M | 0.76% |
| Minimed Group, Inc. | 2M | US$29.9M | 0.50% |
| Comcast Corporation | 1.05M | US$25.7M | 0.43% |
| Senseonics Holdings, Inc. | 4.44M | US$25.2M | 0.42% |
| Atrium Therapeutics, Inc. | 1.5M | US$20.2M | 0.34% |
| Sab Biotherapeutics, Inc. | 2.2M | US$8.57M | 0.14% |
| Bally's Corporation | 448K | US$6.14M | 0.10% |
| Flagstar Bank, N.a. | 32,119 | US$480K | <0.01% |
| Braemar Hotels & Resorts Inc. | 25,951 | US$56,054 | <0.01% |
| Air Products And Chemicals, Inc. | 0 | US$0 | 0.00% |
| Ftai Aviation Ltd. | 0 | US$0 | 0.00% |
| Oscar Health, Inc. | 0 | US$0 | 0.00% |
| Performance Food Group Company | 0 | US$0 | 0.00% |
| Solstice Advanced Materials Inc. | 0 | US$0 | 0.00% |
| Us Foods Holding Corp. | 0 | US$0 | 0.00% |
Source
View original at SEC
Related